ニュース

GRI-0621, an experimental oral therapy for IPF, has so far been tolerated well in an ongoing Phase 2 clinical trial.
Columnist Sam Kirton marks four years since his bilateral lung transplant by reflecting on his health, his family, and his ...
A Texas researcher received a $219,000 NIH grant to study the potential of a treatment for radiation-induced pulmonary ...
Because certain IPF and post-transplant medications can cause sun sensitivity, skin protection is crucial, says columnist Sam Kirton.